Association of TNF-α gene polymorphisms with the occurrence of uterine leiomyoma

Geburtshilfe und Frauenheilkunde

Volumn 67, Issue 1, 2007, Pages 38-42

  Herr, Daniel ^a,b,c   Keck, C ^b   Bettendorf, H ^b   Denschlag, D ^b   Pietrowski, D ^b  

^a UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Leiomyoma; Polymorphism; TNF 308; TNF 863

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARCINOGENESIS; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UTERUS MYOMA;

EID: 33847702152     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-955924     Document Type: Article

References (32)

1. Marino JL, Eskenazi B, Warner M, Samuels S, Vercellini P, Gavoni N et al. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod 2004; 19: 2350-2355
2. Sell SM, Tullis C, Stracner D, Song CY, Gewin J. Minimal interval defined on 7q in uterine leiomyoma. Cancer Genet Cytogenet 2005; 157: 67-69
3. Townsend DE, Sparkes RS, Baluda MC, McClelland G. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 1970; 107: 1168-1173
4. Wu J, Cheng Y. Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations. Zhonghua Fu Chan Ke Za Zhi 1995; 30: 603-607
5. Jakimiuk AJ, Bogusiewicz M, Tarkowski R, Dziduch P, Adamiak A, Wrobel A et al. Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women. Fertil Steril 2004; 82: 1244-1249
6. Shastry BS. SNP alleles in human disease and evolution. J Hum Genet 2002; 47: 561-566
7. Kelada SN, Eaton DL, Wang SS, Rothman NR, Khoury MJ. The role of genetic polymorphisms in environmental health. Environ Health Perspect 2003; 111: 1055-1064
8. Evans WE, McLeod HL. Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 2003; 348: 538-549
9. Hemminki K, Forsti A, Lorenzo Bermejo J. Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events. J Carcinog 2005; 4: 2
10. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996; 334: 1717-1725
11. Hill JA. T-helper 1-type immunity to trophoblast: evidence for a new immunological mechanism for recurrent abortion in women. Hum Reprod 1995; 10: 114-120
12. Hill JA, Choi BC. Maternal immunological aspects of pregnancy success and failure. J Reprod Fertil Suppl 2000; 55: 91-97
13. Kurachi O, Matsuo H, Samoto T, Maruo T. Tumor necrosis factor-alpha expression in human uterine leiomyoma and its down-regulation by progesterone. J Clin Endocrinol Metab 2001; 86: 2275-2280
14. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL et al. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 2005; 191: 969-976
15. Jacob CO, Lee SK, Strassmann G. Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol 1996; 156: 3043-3050
16. Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR et al. TNF receptor-deficient mice reveal divergent roles for p 55 and p 75 in several models of inflammation. J Immunol 1998; 160: 943-952
17. Leek RD, Landers R, Fox SB, Ng F, Harris AL, Lewis CE. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer 1998; 77: 2246-2251
18. Haviv R, Stein R. Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells. J Neurosci Res 1999; 55: 269-277
19. Nakashima J, Tachibana M, Ueno M, Miyajima A, Baba S, Murai M. Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer. Clin Cancer Res 1998; 4: 1743-1748
20. Pietrowski D, Bettendorf H, Keck C, Burkle B, Unfried G, Riener EK et al. Lack of association of TNFalpha gene polymorphisms and recurrent pregnancy loss in Caucasian women. J Reprod Immunol 2004; 61: 51-58
21. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199
22. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J et al. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8: 1443-1449
23. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Yeh LS, Tsai CH. Tumor necrosis factor-alpha-308 promoter and p 53 codon 72 gene polymorphisms in women with leiomyomas. Fertil Steril 2004; 82: 1177-1181
24. Stanczuk GA, Sibanda EN, Tswana SA, Bergstrom S. Polymorphism at the - 308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer. Int J Gynecol Cancer 2003; 13: 148-153
25. Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, Brown NJ et al. Role of tumour necrosis factor gene polymorphisms (- 308 and - 238) in breast cancer susceptibility and severity. Breast Cancer Res 2004; 6: R395-400
26. Carlson DL, Willis MS, White DJ, Horton JW, Giroir BP. Tumor necrosis factor-alpha-induced caspase activation mediates endotoxin-related cardiac dysfunction. Crit Care Med 2005; 33: 1021-1028
27. Pusztai L, Lewis CE, McGee JO. Growth arrest of the breast cancer cell line, T47D, by TNF alpha; cell cycle specificity and signal transduction. Br J Cancer 1993; 67: 290-296
28. Hadfield RM, Manek S, Nakago S, Mukherjee S, Weeks DE, Mardon HJ et al. Absence of a relationship between endometriosis and the N314D polymorphism of galactose-1-phosphate uridyl transferase in a UK population. Mol Hum Reprod 1999; 5: 990-993
29. Hadfield RM, Manek S, Weeks DE, Mardon HJ. Barlow DH, Kennedy SH. Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1. Mol Hum Reprod 2001; 7: 1073-1078
30. Ishii K, Takakuwa K, Mitsui T, Tanaka K. Studies on the human leukocyte antigen-DR in patients with endometriosis: genotyping of HLA-DRB1 alleles. Hum Reprod 2002; 17: 560-563
31. Ishii K, Takakuwa K, Kashima K, Tamura M, Tanaka K. Associations between patients with endometriosis and HLA class II; the analysis of HLA-DQB1 and HLA-DPB1 genotypes. Hum Reprod 2003; 18: 985-989
32. Nakago S, Hadfield RM, Zondervan KT, Mardon H, Manek S, Weeks DE et al. Association between endometriosis and N-acetyl transferase 2 polymorphisms in a UK population. Mol Hum Reprod 2001; 7: 1079-1083